Loading clinical trials...

A Phase I Study of BMS-690514 in Combination With Paclitaxel and Carboplatin | Clinical Trials | Clareo Health

COMPLETEDPhase 1NCT00420186

A Phase I Study of BMS-690514 in Combination With Paclitaxel and Carboplatin

The purpose of this clinical research is to assess the safety and tolerability of BMS-690514 when given in combination with paclitaxel and carboplatin. Paclitaxel and carboplatin will be administered ...

Lead sponsor: Bristol-Myers Squibb•2 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

RECRUITING

WellSpan-THRIVE Cancer QOL Study

NCT07433660 · Cancer (Active Cancer, Meaning Not Being Cancer Free), of Any Stage and Involving Any Treatment/Care Regimen; i.e. Curative, Life-extending, or Palliative, Cancer (Solid Tumors), and more

RECRUITINGPhase 1

A Phase 1 Study of JMT108 in Participants With Advanced Solid Tumors

NCT07317505 · Cancer, Cancer (Solid Tumors)

Not Yet Recruiting

Immune Adverse Events Registry in Onco-Hematologic Patients Treated With Immunotherapy

NCT07198958 · Cancer, Cancer (Colon Cancer, Breast Cancer, Lymphoma, Chronic Lymphoma Leukemia, Multiple Myeloma), and more

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: September 30, 2016Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE1

Enrollment37

Start dateOct 2007

Last updatedSep 30, 2016

Condition

Cancer (Solid Tumors)

Locations shown

Roswell Park Cancer Institute

Buffalo, New York

Penn State Milton S. Hershey Medical Center

Hershey, Pennsylvania

Local Institution

Ottawa, Ontario

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: September 30, 2016Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions